AstraZeneca

In News

How AstraZeneca is using robots to conduct science at new $1 billion Cambridge research center - The Boston Globe

The Boston Globe - Oct 05, 2026

AstraZeneca CEO says Summit drug could drive next generation of cancer combinations after $2 billion investment - CNBC

CNBC - Oct 05, 2026

AstraZeneca CEO Pascal Soriot on Summit ivonescimab combos - Yahoo Finance

Yahoo Finance - Oct 06, 2026

AstraZeneca CEO Soriot says drugmaker can grow without big acquisition - Seeking Alpha

Seeking Alpha - Oct 05, 2026

AstraZeneca opens new global strategic R&D centre in Kendall Square, Cambridge, Massachusetts - AstraZeneca

AstraZeneca - Oct 05, 2026

AstraZeneca opens new R&D centre in Cambridge, US - Pharmaceutical Technology

Pharmaceutical Technology - Oct 06, 2026

‘We’re here at the party now:’ AstraZeneca opens new Kendall hub with big hiring plans - The Business Journals

The Business Journals - Oct 05, 2026

AstraZeneca cuts ribbon on new R&D facility in Massachusetts - pharmaphorum

pharmaphorum - Oct 06, 2026

AstraZeneca CEO Pascal Soriot on Summit ivonescimab combos - Quartz

Quartz - Oct 06, 2026

AstraZeneca Opens New Global Strategic R&D Centre in Cambridge - Oncodaily

Oncodaily - Oct 06, 2026

AstraZeneca opens new global strategic R&D center in USA - The Pharma Letter

The Pharma Letter - Oct 06, 2026

Citi raises AstraZeneca target to £186 as tozorakimab prospects improve - Proactive financial news

Proactive financial news - Oct 06, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment